Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

Effect of Daytime Blue-enriched LED Light on the Nighttime Circadian Melatonin Inhibition of Hepatoma 7288CTC Warburg Effect and Progression.

Dauchy RT, Wren-Dail MA, Dupepe LM, Hill SM, Xiang S, Anbalagan M, Belancio VP, Dauchy EM, Blask DE.

Comp Med. 2018 Aug 1;68(4):269-279. doi: 10.30802/AALAS-CM-17-000107. Epub 2018 Jun 6.

2.

Development and Characterization of a Novel Congenic Rat Strain for Obesity and Cancer Research.

O'Neill AM, Gillaspie EA, Burrington CM, Lynch DT, Dauchy RT, Blask DE, Tirrell PC, Reis BA, Horsman MJ, Greene MW.

Nutr Cancer. 2018 Feb-Mar;70(2):278-287. doi: 10.1080/01635581.2018.1412483. Epub 2018 Jan 9.

PMID:
29313726
3.

Health consequences of electric lighting practices in the modern world: A report on the National Toxicology Program's workshop on shift work at night, artificial light at night, and circadian disruption.

Lunn RM, Blask DE, Coogan AN, Figueiro MG, Gorman MR, Hall JE, Hansen J, Nelson RJ, Panda S, Smolensky MH, Stevens RG, Turek FW, Vermeulen R, Carreón T, Caruso CC, Lawson CC, Thayer KA, Twery MJ, Ewens AD, Garner SC, Schwingl PJ, Boyd WA.

Sci Total Environ. 2017 Dec 31;607-608:1073-1084. doi: 10.1016/j.scitotenv.2017.07.056. Epub 2017 Jul 27. Review.

4.

Effect of Isoflurane Anesthesia on Circadian Metabolism and Physiology in Rats.

Wren-Dail MA, Dauchy RT, Blask DE, Hill SM, Ooms TG, Dupepe LM, Bohm RP Jr.

Comp Med. 2017 Mar 1;67(2):138-146.

5.

Melatonin Represses Metastasis in Her2-Postive Human Breast Cancer Cells by Suppressing RSK2 Expression.

Mao L, Summers W, Xiang S, Yuan L, Dauchy RT, Reynolds A, Wren-Dail MA, Pointer D, Frasch T, Blask DE, Hill SM.

Mol Cancer Res. 2016 Nov;14(11):1159-1169. Epub 2016 Aug 17.

6.

Effects of Colored Enrichment Devices on Circadian Metabolism and Physiology in Male Sprague-Dawley Rats.

Wren-Dail MA, Dauchy RT, Ooms TG, Baker KC, Blask DE, Hill SM, Dupepe LM, Bohm RP Jr.

Comp Med. 2016;66(5):384-391.

7.

Effects of Daytime Exposure to Light from Blue-Enriched Light-Emitting Diodes on the Nighttime Melatonin Amplitude and Circadian Regulation of Rodent Metabolism and Physiology.

Dauchy RT, Wren-Dail MA, Hoffman AE, Hanifin JP, Warfield B, Brainard GC, Hill SM, Belancio VP, Dauchy EM, Blask DE.

Comp Med. 2016;66(5):373-383.

8.

Daytime Blue Light Enhances the Nighttime Circadian Melatonin Inhibition of Human Prostate Cancer Growth.

Dauchy RT, Hoffman AE, Wren-Dail MA, Hanifin JP, Warfield B, Brainard GC, Xiang S, Yuan L, Hill SM, Belancio VP, Dauchy EM, Smith K, Blask DE.

Comp Med. 2015 Dec;65(6):473-85.

9.

Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma.

Mao L, Dauchy RT, Blask DE, Dauchy EM, Slakey LM, Brimer S, Yuan L, Xiang S, Hauch A, Smith K, Frasch T, Belancio VP, Wren MA, Hill SM.

J Pineal Res. 2016 Mar;60(2):167-77. doi: 10.1111/jpi.12298. Epub 2015 Dec 23.

PMID:
26607298
10.

Melatonin: an inhibitor of breast cancer.

Hill SM, Belancio VP, Dauchy RT, Xiang S, Brimer S, Mao L, Hauch A, Lundberg PW, Summers W, Yuan L, Frasch T, Blask DE.

Endocr Relat Cancer. 2015 Jun;22(3):R183-204. doi: 10.1530/ERC-15-0030. Epub 2015 Apr 15. Review.

11.

Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.

Xiang S, Dauchy RT, Hauch A, Mao L, Yuan L, Wren MA, Belancio VP, Mondal D, Frasch T, Blask DE, Hill SM.

J Pineal Res. 2015 Aug;59(1):60-9. doi: 10.1111/jpi.12239. Epub 2015 Apr 20.

12.

The influence of red light exposure at night on circadian metabolism and physiology in Sprague-Dawley rats.

Dauchy RT, Wren MA, Dauchy EM, Hoffman AE, Hanifin JP, Warfield B, Jablonski MR, Brainard GC, Hill SM, Mao L, Dobek GL, Dupepe LM, Blask DE.

J Am Assoc Lab Anim Sci. 2015 Jan;54(1):40-50.

13.

The aging clock and circadian control of metabolism and genome stability.

Belancio VP, Blask DE, Deininger P, Hill SM, Jazwinski SM.

Front Genet. 2015 Jan 14;5:455. doi: 10.3389/fgene.2014.00455. eCollection 2014. Review.

14.

Light exposure at night disrupts host/cancer circadian regulatory dynamics: impact on the Warburg effect, lipid signaling and tumor growth prevention.

Blask DE, Dauchy RT, Dauchy EM, Mao L, Hill SM, Greene MW, Belancio VP, Sauer LA, Davidson L.

PLoS One. 2014 Aug 6;9(8):e102776. doi: 10.1371/journal.pone.0102776. eCollection 2014.

15.

Circadian and melatonin disruption by exposure to light at night drives intrinsic resistance to tamoxifen therapy in breast cancer.

Dauchy RT, Xiang S, Mao L, Brimer S, Wren MA, Yuan L, Anbalagan M, Hauch A, Frasch T, Rowan BG, Blask DE, Hill SM.

Cancer Res. 2014 Aug 1;74(15):4099-110. doi: 10.1158/0008-5472.CAN-13-3156.

16.

Regulation of L1 expression and retrotransposition by melatonin and its receptor: implications for cancer risk associated with light exposure at night.

deHaro D, Kines KJ, Sokolowski M, Dauchy RT, Streva VA, Hill SM, Hanifin JP, Brainard GC, Blask DE, Belancio VP.

Nucleic Acids Res. 2014 Jul;42(12):7694-707. doi: 10.1093/nar/gku503. Epub 2014 Jun 9.

17.

Breast cancer and circadian disruption from electric lighting in the modern world.

Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME.

CA Cancer J Clin. 2014 May-Jun;64(3):207-18. doi: 10.3322/caac.21218. Epub 2013 Dec 24. Review.

18.

Effect of different spectral transmittances through tinted animal cages on circadian metabolism and physiology in Sprague-Dawley rats.

Wren MA, Dauchy RT, Hanifin JP, Jablonski MR, Warfield B, Brainard GC, Blask DE, Hill SM, Ooms TG, Bohm RP Jr.

J Am Assoc Lab Anim Sci. 2014 Jan;53(1):44-51.

19.

Molecular deficiency (ies) in MT₁ melatonin signaling pathway underlies the melatonin-unresponsive phenotype in MDA-MB-231 human breast cancer cells.

Mao L, Yuan L, Xiang S, Zeringue SB, Dauchy RT, Blask DE, Hauch A, Hill SM.

J Pineal Res. 2014 Apr;56(3):246-53. doi: 10.1111/jpi.12117. Epub 2014 Jan 18.

20.

Effect of spectral transmittance through red-tinted rodent cages on circadian metabolism and physiology in nude rats.

Dauchy RT, Wren MA, Dauchy EM, Hanifin JP, Jablonski MR, Warfield B, Brainard GC, Hill SM, Mao L, Dupepe LM, Ooms TG, Blask DE.

J Am Assoc Lab Anim Sci. 2013 Nov;52(6):745-55.

21.

Insulin and IGF1 enhance IL-17-induced chemokine expression through a GSK3B-dependent mechanism: a new target for melatonin's anti-inflammatory action.

Ge D, Dauchy RT, Liu S, Zhang Q, Mao L, Dauchy EM, Blask DE, Hill SM, Rowan BG, Brainard GC, Hanifin JP, Cecil KS, Xiong Z, Myers L, You Z.

J Pineal Res. 2013 Nov;55(4):377-87. doi: 10.1111/jpi.12084. Epub 2013 Aug 20.

22.

Adverse health effects of nighttime lighting: comments on American Medical Association policy statement.

Stevens RG, Brainard GC, Blask DE, Lockley SW, Motta ME.

Am J Prev Med. 2013 Sep;45(3):343-6. doi: 10.1016/j.amepre.2013.04.011.

PMID:
23953362
23.

Age-related decline in melatonin and its MT1 receptor are associated with decreased sensitivity to melatonin and enhanced mammary tumor growth.

Hill SM, Cheng C, Yuan L, Mao L, Jockers R, Dauchy B, Blask DE.

Curr Aging Sci. 2013 Feb;6(1):125-33. Review.

PMID:
23895529
24.

Effects of spectral transmittance through standard laboratory cages on circadian metabolism and physiology in nude rats.

Dauchy RT, Dauchy EM, Hanifin JP, Gauthreaux SL, Mao L, Belancio VP, Ooms TG, Dupepe LM, Jablonski MR, Warfield B, Wren MA, Brainard GC, Hill SM, Blask DE.

J Am Assoc Lab Anim Sci. 2013 Mar;52(2):146-56.

25.

Oscillation of clock and clock controlled genes induced by serum shock in human breast epithelial and breast cancer cells: regulation by melatonin.

Xiang S, Mao L, Duplessis T, Yuan L, Dauchy R, Dauchy E, Blask DE, Frasch T, Hill SM.

Breast Cancer (Auckl). 2012;6:137-50. Epub 2012 Sep 13.

26.

Circadian gating of epithelial-to-mesenchymal transition in breast cancer cells via melatonin-regulation of GSK3β.

Mao L, Dauchy RT, Blask DE, Slakey LM, Xiang S, Yuan L, Dauchy EM, Shan B, Brainard GC, Hanifin JP, Frasch T, Duplessis TT, Hill SM.

Mol Endocrinol. 2012 Nov;26(11):1808-20. doi: 10.1210/me.2012-1071. Epub 2012 Sep 21. Erratum in: Mol Endocrinol. 2013 Jan;27(1):188.

27.

Impaired mouse mammary gland growth and development is mediated by melatonin and its MT1G protein-coupled receptor via repression of ERα, Akt1, and Stat5.

Xiang S, Mao L, Yuan L, Duplessis T, Jones F, Hoyle GW, Frasch T, Dauchy R, Blask DE, Chakravarty G, Hill SM.

J Pineal Res. 2012 Oct;53(3):307-18. doi: 10.1111/j.1600-079X.2012.01000.x. Epub 2012 May 14.

28.

A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.

Dauchy RT, Dauchy EM, Mao L, Belancio VP, Hill SM, Blask DE.

Comp Med. 2012 Apr;62(2):99-108.

29.

Work at night and breast cancer--report on evidence-based options for preventive actions.

Bonde JP, Hansen J, Kolstad HA, Mikkelsen S, Olsen JH, Blask DE, Härmä M, Kjuus H, de Koning HJ, Olsen J, Møller M, Schernhammer ES, Stevens RG, Åkerstedt T.

Scand J Work Environ Health. 2012 Jul;38(4):380-90. doi: 10.5271/sjweh.3282. Epub 2012 Feb 20.

30.

Melatonin and associated signaling pathways that control normal breast epithelium and breast cancer.

Hill SM, Blask DE, Xiang S, Yuan L, Mao L, Dauchy RT, Dauchy EM, Frasch T, Duplesis T.

J Mammary Gland Biol Neoplasia. 2011 Sep;16(3):235-45. doi: 10.1007/s10911-011-9222-4. Epub 2011 Jul 20. Review.

PMID:
21773809
31.

Eliminating animal facility light-at-night contamination and its effect on circadian regulation of rodent physiology, tumor growth, and metabolism: a challenge in the relocation of a cancer research laboratory.

Dauchy RT, Dupepe LM, Ooms TG, Dauchy EM, Hill CR, Mao L, Belancio VP, Slakey LM, Hill SM, Blask DE.

J Am Assoc Lab Anim Sci. 2011 May;50(3):326-36.

32.

Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night.

Blask DE, Hill SM, Dauchy RT, Xiang S, Yuan L, Duplessis T, Mao L, Dauchy E, Sauer LA.

J Pineal Res. 2011 Oct;51(3):259-69. doi: 10.1111/j.1600-079X.2011.00888.x. Epub 2011 May 24. Review.

33.

Light at night activates IGF-1R/PDK1 signaling and accelerates tumor growth in human breast cancer xenografts.

Wu J, Dauchy RT, Tirrell PC, Wu SS, Lynch DT, Jitawatanarat P, Burrington CM, Dauchy EM, Blask DE, Greene MW.

Cancer Res. 2011 Apr 1;71(7):2622-31. doi: 10.1158/0008-5472.CAN-10-3837. Epub 2011 Feb 10.

34.

Dark-phase light contamination disrupts circadian rhythms in plasma measures of endocrine physiology and metabolism in rats.

Dauchy RT, Dauchy EM, Tirrell RP, Hill CR, Davidson LK, Greene MW, Tirrell PC, Wu J, Sauer LA, Blask DE.

Comp Med. 2010 Oct;60(5):348-56.

35.

Declining melatonin levels and MT1 receptor expression in aging rats is associated with enhanced mammary tumor growth and decreased sensitivity to melatonin.

Hill SM, Cheng C, Yuan L, Mao L, Jockers R, Dauchy B, Frasch T, Blask DE.

Breast Cancer Res Treat. 2011 May;127(1):91-8. doi: 10.1007/s10549-010-0958-0. Epub 2010 Jun 12.

PMID:
20549340
36.
37.

Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts.

Dauchy RT, Blask DE, Dauchy EM, Davidson LK, Tirrell PC, Greene MW, Tirrell RP, Hill CR, Sauer LA.

J Pineal Res. 2009 Aug;47(1):32-42. doi: 10.1111/j.1600-079X.2009.00686.x. Epub 2009 May 27.

PMID:
19486272
38.

Melatonin, sleep disturbance and cancer risk.

Blask DE.

Sleep Med Rev. 2009 Aug;13(4):257-64. doi: 10.1016/j.smrv.2008.07.007. Epub 2008 Dec 17. Review.

PMID:
19095474
39.

Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases.

Stevens RG, Blask DE, Brainard GC, Hansen J, Lockley SW, Provencio I, Rea MS, Reinlib L.

Environ Health Perspect. 2007 Sep;115(9):1357-62.

40.

Inhibition of fatty acid transport and proliferative activity in tissue-isolated human squamous cell cancer xenografts perfused in situ with melatonin or eicosapentaenoic or conjugated linoleic acids.

Dauchy RT, Dauchy EM, Davidson LK, Krause JA, Lynch DT, Tirrell PC, Tirrell RP, Sauer LA, Van der Riet P, Blask DE.

Comp Med. 2007 Aug;57(4):377-82.

PMID:
17803052
41.

Dietary fish oil deactivates a growth-promoting signaling pathway in hepatoma 7288CTC in Buffalo rats.

Smith LC, Dauchy EM, Dauchy RT, Sauer LA, Blask DE, Davidson LK, Krause JA, Lynch DT.

Nutr Cancer. 2006;56(2):204-13.

PMID:
17474866
42.

Dietary factors and growth and metabolism in experimental tumors.

Sauer LA, Blask DE, Dauchy RT.

J Nutr Biochem. 2007 Oct;18(10):637-49. Epub 2007 Apr 5. Review.

PMID:
17418560
43.

Human cancer xenograft perfusion in situ in rats: a new perfusion system that minimizes delivery time and maintains normal tissue physiology and responsiveness to growth-inhibitory agents.

Dauchy EM, Dauchy RT, Davidson LK, Lynch DT, Krause JA, Blue LM, Sauer LA, Blask DE.

J Am Assoc Lab Anim Sci. 2006 May;45(3):38-44.

PMID:
16642969
44.

Light during darkness and cancer: relationships in circadian photoreception and tumor biology.

Jasser SA, Blask DE, Brainard GC.

Cancer Causes Control. 2006 May;17(4):515-23. Review.

PMID:
16596305
45.

Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats.

Blask DE, Brainard GC, Dauchy RT, Hanifin JP, Davidson LK, Krause JA, Sauer LA, Rivera-Bermudez MA, Dubocovich ML, Jasser SA, Lynch DT, Rollag MD, Zalatan F.

Cancer Res. 2005 Dec 1;65(23):11174-84.

46.

Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.

Blask DE, Dauchy RT, Sauer LA.

Endocrine. 2005 Jul;27(2):179-88. Review.

PMID:
16217131
47.
48.

Conjugated linoleic acid isomers and trans fatty acids inhibit fatty acid transport in hepatoma 7288CTC and inguinal fat pads in Buffalo rats.

Sauer LA, Dauchy RT, Blask DE, Krause JA, Davidson LK, Dauchy EM, Welham KJ, Coupland K.

J Nutr. 2004 Aug;134(8):1989-97.

PMID:
15284388
49.

Re: Melatonin and breast cancer: a prospective study.

Hrushesky WJ, Blask DE.

J Natl Cancer Inst. 2004 Jun 2;96(11):888-9. No abstract available.

PMID:
15173281
50.

Supplemental Content

Loading ...
Support Center